- Home
- ORGO vs DGICB Comparison
ORGO vs DGICB Comparison
Compare ORGO & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORGO | DGICB |
|---|---|---|
| Founded | 1985 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.4M | 562.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORGO | DGICB |
|---|---|---|
| Price | $4.80 | $15.89 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 2.0K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | N/A | ★ 219.91 |
| EPS | N/A | ★ 2.38 |
| Revenue | $465,218,000.00 | ★ $987,826,105.00 |
| Revenue This Year | $8.14 | $2.26 |
| Revenue Next Year | $6.33 | $3.46 |
| P/E Ratio | ★ N/A | $8.36 |
| Revenue Growth | ★ 2.24 | 0.89 |
| 52 Week Low | $2.61 | $13.19 |
| 52 Week High | $7.08 | $20.46 |
Technical Indicators
Market Signals| Indicator | ORGO | DGICB |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 48.92 |
| Support Level | $4.66 | $15.68 |
| Resistance Level | $5.83 | $17.06 |
| Average True Range (ATR) | 0.20 | 0.40 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 18.13 | 28.32 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.